BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18836473)

  • 1. The Janus face of dendritic cells in cancer.
    Chaput N; Conforti R; Viaud S; Spatz A; Zitvogel L
    Oncogene; 2008 Oct; 27(45):5920-31. PubMed ID: 18836473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L; Carbone DP
    Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth.
    Lin A; Schildknecht A; Nguyen LT; Ohashi PS
    Immunol Lett; 2010 Jan; 127(2):77-84. PubMed ID: 19778555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
    Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
    J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
    Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
    Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells and cancer immunosurveillance.
    Waldhauer I; Steinle A
    Oncogene; 2008 Oct; 27(45):5932-43. PubMed ID: 18836474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells--why can they help and hurt us.
    Schäkel K
    Exp Dermatol; 2009 Mar; 18(3):264-73. PubMed ID: 19183400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capitalizing on the immunogenicity of dying tumor cells.
    Fonseca C; Dranoff G
    Clin Cancer Res; 2008 Mar; 14(6):1603-8. PubMed ID: 18347160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancer.
    Chouaib S; Meslin F; Thiery J; Mami-Chouaib F
    Clin Immunol; 2009 Jan; 130(1):34-40. PubMed ID: 19013109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive influences in the immune response to cancer.
    Bronte V; Mocellin S
    J Immunother; 2009 Jan; 32(1):1-11. PubMed ID: 19307988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer role of dendritic cells (DC) in human and experimental cancers--a review.
    Becker Y
    Anticancer Res; 1992; 12(2):511-20. PubMed ID: 1349798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taking dendritic cells into medicine.
    Steinman RM; Banchereau J
    Nature; 2007 Sep; 449(7161):419-26. PubMed ID: 17898760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
    Li CD; Zhang WY; Yuan CL; Han LY
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour escape from immune surveillance through dendritic cell inactivation.
    Vicari AP; Caux C; Trinchieri G
    Semin Cancer Biol; 2002 Feb; 12(1):33-42. PubMed ID: 11926410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From cancer immunosurveillance to cancer immunotherapy.
    Stagg J; Johnstone RW; Smyth MJ
    Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
    Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ
    J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?
    Steinbrink K; Mahnke K; Grabbe S; Enk AH; Jonuleit H
    Hum Immunol; 2009 May; 70(5):289-93. PubMed ID: 19217922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.